Fundamental Analysis
15 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -27.2% | -115.9% | 0 / 3 | +36.1% | -6.18 pp | -1.29 pp | +5.3% | 2.06 | 26.18 | 1.124 | +36,1% | 17,5 | −25,6% | 26.18 | 19.46 | +34,5% |
| Pts | 0 | 0 | 0 | 12 | 0 | 4 | 0 | -4 | 4 | |||||||
Valuation annotation:Price: 16.900 (close price on 2026-10-19)EPS (TTM): 645,6
Financial charts
1.Revenue & growth
VND bn1.124Q2/26
1.Revenue & growth
VND bn1.124Q2/26
2.Profit & growth
VND bn17,3Q2/26
3.Profit mix (Penman)
VND bn78,9Q2/26
4.Margins & cost structure
%16.1%Q2/26
5.Returns & cash cycle
% · days5.8%Q2/26
6.Earnings quality & cash
VND bn206Q2/26
7.Asset structure
VND bn4.262Q2/26
8.Funding & debt health
VND bn · times4.262Q2/26
9.Revenue backlog
VND bn74,1Q2/26
10.Valuation
times · %26,2×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %177Q2/26
Adjusted EPS growth, latest quarter
-27.2%
Average adjusted EPS growth, 3 quarters
-26.8%
averaged over 2 quarter(s)
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26